Proxy Solicitation & Information Statement • May 11, 2015
Preview not available for this file type.
Download Source FileDFAN14A 1 c81374_dfan14a.htm Field: Rule-Page
Field: /Rule-Page
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
| Filed by the Registrant o |
|---|
| Check the appropriate box: |
| o | Preliminary Proxy Statement |
|---|---|
| o | Confidential, for Use of the Commission Only (as permitted by |
| Rule 14a-6(e)(2)) | |
| o | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| o | Soliciting Material under §240.14a-12 |
E. I. du Pont de Nemours and Company
(Name of Registrant as Specified In Its Charter)
Trian Fund Management, L.P.
Trian Fund Management GP, LLC
Trian Partners, L.P.
Trian Partners Strategic Investment Fund, L.P.
Trian Partners Strategic Investment Fund II, L.P.
Trian Partners Master Fund, L.P.
Trian Partners Parallel Fund I, L.P.
Trian Partners Master Fund (ERISA), L.P.
Trian Partners Strategic Investment Fund-A, L.P.
Trian Partners Strategic Investment Fund-D, L.P.
Trian Partners Strategic Investment Fund-N, L.P.
Trian SPV (SUB) VIII, L.P.
Trian Partners Fund (Sub)-G, L.P.
Trian Partners Fund (Sub)-G II, L.P.
Nelson Peltz
Peter W. May
Edward P. Garden
John H. Myers
Arthur B. Winkleblack
Robert J. Zatta
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Field: Page; Sequence: 1
Field: /Page
PAYMENT OF FILING FEE (Check the appropriate box):
| x | No fee required |
|---|---|
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| 1) | Title of each class of securities to which transaction
applies: |
| --- | --- |
| 2) | Aggregate number of securities to which transaction
applies: |
| 3) | Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was
determined): |
| 4) | Proposed maximum aggregate value of transaction: |
| 5) | Total fee paid: |
| o | Fee paid previously with preliminary materials. |
|---|---|
| o | Check box if any part of the fee is offset as provided by Exchange Act |
| Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by | |
| registration statement number, or the Form or Schedule and the date of its filing. |
| 1) | Amount Previously Paid: |
|---|---|
| 2) | Form, Schedule or Registration Statement No.: |
| 3) | Filing Party: |
| 4) | Date Filed: |
Field: Page; Sequence: 2
Field: /Page
Trian Fund Management, L.P. has, and may from time to time in the future, distribute the following materials to stockholders of E.I. du Pont de Nemours and Company and certain other persons:
DuPont: Focus on the May 13 Annual Meeting of Stockholders
We always prefer to work with management teams and boards out of the public eye. In the case of DuPont, we worked for nearly 18 months “behind the scenes.” Though we have never seen a company so unwilling to “engage,” we were very patient and respectful as we attempted to show management and the lead director a path to making DuPont’s business segments best-in-class operationally. We explained that the company would not achieve management’s publicly stated goals of 7% sales growth and 12% EPS growth while five of their seven operating segments underperform peers and the company’s own targets. It is important to understand that in December 2013 the lead director encouraged us to hold the Board accountable if the company did not achieve its targets in 2014. After the company lowered guidance for the third year in a row in mid-year 2014, we asked for one board seat for Ed, which was rejected, and then later for Nelson, which was also rejected. We simply could no longer be passive while the management team and Board continued to falter. As a result, we launched our proxy contest in early 2015, our first since Heinz in 2006.
Over the last several months, members of our DuPont team (consisting of Nelson, Ed, partners Matt Peltz, Brian Schorr and Brian Jacoby along with other members of the investment team) have met with approximately 50 DuPont stockholders, representing about 41% of the shares outstanding. We have approached these conversations clinically and quantitatively, with a focus on Trian’s plan to fix the company’s chronic underperformance (e.g., EPS in 2012, 2013, 2014 was, and according to company guidance in 2015 will be, lower than in 2011), poor board oversight and weak corporate governance. We believe that our fellow owners of DuPont have been receptive to our analysis and the credentials of our four nominees, Nelson, John Myers (Former President & CEO of GE Asset Management), Art Winkleblack (Former EVP & CFO at H.J. Heinz) and Bob Zatta (Former Acting CEO and long-time CFO at Rockwood Holdings) (and Ed, as the alternate).
We have also tried to reach a settlement with DuPont since launching the proxy contest, but DuPont’s leadership has been highly resistant to having a Trian principal on the board, something we believe is necessary to eliminate management’s “information advantage” over the Board and to eliminate misleading and dangerous rhetoric. Importantly, when a Trian principal is on a board, the relevant members of the Trian investment team provide our representative(s) and through them the rest of the Board with extensive analytical support. In addition, the Trian team develops relationships up and down the organization chart. As a result, we can better evaluate operating and strategic opportunities, which, in turn, accrues to the benefit of the entire board in its oversight of the company and its fiduciary responsibility to shareholders. While DuPont has worked to portray our potential board involvement as “intrusive” during the proxy contest, history suggests the result is a long-lasting and positive impact on company performance and shareholder value through collaborative relationships with management and other board members. This is our “secret sauce” and is the method by which we are able to turn around companies that are struggling to grow earnings. Annual adjusted EPS growth for Trian investments during the 5-year period prior to Trian’s investment are an average of 3.5%, whereas EPS growth during Trian’s investment period averages 8.3%, nearly 2.5x greater i . A number of executives and other business leaders who have served or serve with us on boards or with whom we have worked have provided statements regarding our work in the boardroom and with our portfolio companies. These statements are attached in Appendix C.
Field: Rule-Page
Field: /Rule-Page
i See Appendix B for accompanying data, notes and disclaimers
Field: Page; Sequence: 3
Field: /Page
The DuPont Annual Meeting of stockholders is on May 13 th . The final stage of the proxy contest began after the issuance of the recommendations of the leading independent significant proxy advisors: Institutional Shareholder Services, Inc. (“ISS”), Glass Lewis and Egan-Jones. These recommendations are a focal point for us, DuPont’s leadership, and the company’s institutional stockholders, who typically begin to vote after the proxy advisors have weighed in. ii
– On April 27 th , ISS recommended that DuPont stockholders vote for Nelson and John H. Myers, saying that we made a compelling case for change, and that the “…Trian method, providing its executives who go on boards with extensive analytic support throughout their tenures, may be not simply desirable, but necessary to drive the appropriate change.” Their recommendation also highlighted the strength of Trian’s other nominees, Robert Zatta and Art Winkleblack, saying they’re “well-qualified, particularly given their experience as CFO’s with significant strategic responsibilities.”
– On April 28 th , Glass Lewis recommended that DuPont stockholders vote for Nelson. In its analysis, Glass Lewis noted that “owing to Trian’s $1.8 billion at stake, Mr. Peltz is uniquely qualified, perhaps more than any other director nominee this year, to promote an ownership mentality that comes from a large and more direct financial interest in the Company. We also note that his addition may help restore any credibility lost in the eyes of investors following the CEO’s recent stock sales.” They went on to say that “in this case, we believe Trian has identified legitimate concerns at DuPont, primarily related to operational execution and management accountability, which we believe substantiate the Dissident’s central thesis that the Company is not performing to its full potential -- and that significant value may yet be created by further addressing Trian’s ongoing criticisms.”
– On May 4 th , Egan-Jones recommended that DuPont stockholders vote for all four of Trian’s nominees. In its report, Egan-Jones noted that, “In arriving at this conclusion, we have considered the following; there is ample evidence of unnecessary large administrative costs, the company as a whole as well as the Board of Directors seems to lack focus, our belief that current economic conditions along with firm size are protecting the Company from the market, and the measured disciplined approach proposed by the dissidents to correct these issues.”
Needless to say, we were gratified that ISS, Glass Lewis and Egan-Jones, support our efforts to hold the board accountable for DuPont’s consistent underperformance and are hopeful that stockholders will consider these independent views as they determine which 12 nominees to support for election to the DuPont board.
Field: Rule-Page
Field: /Rule-Page
ii Trian neither sought nor obtained permission to publish the statements from ISS, Glass Lewis and Egan-Jones contained herein
Field: Page; Sequence: 4
Field: /Page
In the meantime, we would note that regardless of the outcome on May 13 th , our investment in DuPont is truly a “win” for Trian and DuPont stockholders with total shareholder return up significantly since we invested. Our presence and our quiet (and more recent public) prodding has also resulted in a number of significant initiatives at DuPont since we went public with our position in mid-2013, including:
o The Fresh Start Initiative, targeting $925 million of cost saving
o Spinning off Chemours tax efficiently (versus selling for cash)
o Other divestitures, including Glass Lamination Solutions, DuPont Hotel/Country Club/Theater and Cooper Fungicide Business
o A $5 billion share buyback program
o Commitment to return $4 billion of capital to stockholders resulting from the Chemours spin
o Appointment of Messrs. Breen and Gallogly to the board of directors
o Amendment of key performance indicators for 2015 compensation
o Limited enhancement of Chemours proposed corporate governance
We believe there is still significant room for growth. We look forward to finishing the proxy contest and feel confident we can make a difference on the DuPont board if elected.
On April 21, 2015, Trian hosted a lunch presentation for DuPont shareholders and sell-side analysts to discuss DuPont’s underperformance and to further our case for board representation at DuPont. That same morning, DuPont reported Q1 2015 earnings that were “more of the same.” Operating EPS came in at $1.34 per share, a 15% year-over-year decline, primarily driven by a 9.4% year-over-year decline in revenue across the business, driven by weakness in the Agriculture and Performance Chemicals businesses. Foreign currency headwinds played a large part in the year-over-year declines (DuPont’s business is ~55% outside of North America); however, even excluding the impact of currency, results were still uninspiring: organic revenue declined at -1% and Operating EPS (ex-currency) grew at 1%. DuPont revised guidance for the full year to the “low end” of the previously communicated range of $4.00 - $4.20.
It is important to note that the first quarter of any given year for DuPont usually represents approximately 40% of full year earnings, as the earnings of DuPont’s agriculture segment (which accounts for ~40% of the company’s full year earnings) are heavily weighted in the first quarter (farmers’ primary planting season). As such, Trian questions whether DuPont can meet the revised guidance, given that the company is lapping significant “one-timers” taken in 2014 (one-time reduction in performance-based compensation and non-recurring gains on sales). We estimate that DuPont must grow EPS approximately 29% in the remaining three quarters of the year to meet its revised guidance.
Field: Page; Sequence: 5
Field: /Page
Other Q1 2015 developments of note:
DuPont increased its quarterly dividend to $0.47/share, a 4% increase
DuPont’s 2015 guidance now contemplates $0.40 of cost cuts related to the “Fresh Start Initiative”, up from the previous estimate of $0.35
The company committed to a July 1, 2015 spin date for Chemours (the Performance Chemicals segment), which was initially announced in October 2013
| ● | On May 4, Egan-Jones recommended DuPont shareholders vote on Trian’s GOLD proxy card to elect Nelson, John Myers, Arthur Winkleback and Robert Zatta to the DuPont Board of Directors | |
|---|---|---|
| • | On April 29, Glass Lewis recommended DuPont shareholders vote on Trian’s GOLD proxy card to elect Nelson to the DuPont Board of Directors | |
| • | On April 27, ISS recommended DuPont shareholders vote on Trian’s GOLD proxy card to elect Nelson Peltz and John Myers to the DuPont Board of Directors | |
| • | On April 21, DuPont announced Q1 2015 results: | |
| – | EPS of $1.34, which includes a $0.25 per share negative impact from currency in segment results | |
| – | Sales were $9.2 billion, down 9% versus prior year primarily due to impacts from currency (6%), portfolio changes (2%) and industry-wide headwinds in Agriculture and Performance Chemicals. | |
| – | Cost reductions from operational redesign contributed $0.10 per share to first-quarter operating earnings; 2015 total cost savings expected to increase from $0.35 to approximately $0.40 per share. | |
| – | Estimated negative currency impact in 2015 increased to approximately $0.80 per share, up from the $0.60 per share previously communicated; Company now expects to be at the low end of the previously communicated outlook range of $4.00-$4.20 operating earnings per share, including Performance Chemicals segment. | |
| • | On February 5, DuPont appointed Edward Breen and James Gallogly as independent directors to the Board, replacing long-time directors Curtis Crawford and Richard Brown, who will serve as directors on the board of Chemours post spin-off (expected to be completed July 2015) |
Field: Page; Sequence: 6
Field: /Page
Appendix B: Excerpts from “Trian’s Discussion Points” – April 21, 2015
Filed with the Securities Exchange Commission on April 21, 2015
Trian Has A Demonstrated Ability To Drive Operational Improvements
§ Trian has a long track record of working with its portfolio companies to help grow earnings
§ We have seen the impact of our active involvement and constructive engagement stretch well beyond just the period of our investment
§ As the charts below indicate, when measuring annual adjusted EPS growth since the time of Trian’s initial investment through the present, our portfolio companies have on average generated significant EPS outperformance
§ B ased on this track record, Trian believes it can help DuPont grow earnings significantly
Source: Company filings, Bloomberg
(1) Adjusted earnings per share (“EPS”) is defined as net income excluding specifically identified items divided by the weighted average number of diluted shares outstanding during the fiscal year. Trian believes that using EPS on an adjusted basis for this analysis provides a more accurate representation of a company’s operating performance across time periods. Adjustments to net income include, but are not limited to, certain non-cash items (e.g., impairments, intangibles amortization, non-cash interest), non-recurring items (e.g., one-time gains and/or losses, restructuring costs, extraordinary items) and non-operational items (e.g., acquisition costs, legal settlements, hedges).
(2) “Core and Other Trian Investments” refers to the same population of Trian investments used for the Total Shareholder Return (TSR) analysis described on the following page of this letter. Please refer to the summary chart on such page for the names of the “Core Trian Investments” and “Other Trian Investments” used in the TSR analysis and the criteria used to select such investments. Such investments do not represent all of the investments purchased or sold for Trian’s clients.
(3) The Annual Adjusted EPS Growth during the “Prior 5-Year Period” represents the compound annual growth rate (“CAGR”) calculated using the company’s Adjusted EPS on the “pre-investment date” versus the Adjusted EPS five years prior to such date. For purposes of this analysis, the “pre-investment date” for each Trian portfolio company was established as the portfolio company’s (forward or backward-looking) fiscal year-end that was closest to Trian’s initial investment date.
(4) The Annual Adjusted EPS Growth during the Time Period represents the CAGR calculated using the company’s Adjusted EPS on the “pre-investment date” versus the Adjusted EPS through either calendar year 2014 or the last full fiscal year prior to the last day of public trading of the company’s stock.
Note: While Trian may believe that earnings per share growth during the Time Period is attributable in large part to the cumulative effects of the implementation of operational and strategic initiatives during the period of Trian’s active involvement and beyond, there is no objective method to confirm what portion of such growth was attributable to Trian’s efforts and what may have been attributable to other factors. The EPS Growth figures on this page should not construed as an indication of the performance of the funds managed by Trian and it should not be assumed that any or all of the investments included in this analysis were or will be profitable in any of the funds managed by Trian. Past performance is not an indication of future results.
Field: Page; Sequence: 7
Field: /Page
Trian Has A Track Record Of Helping Companies Outperform The Market Over The Long Term
§ Trian has a track record of adding value in the Boardroom, improving both operating results and share price performance.
| Cumulative | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Shareholder | Annual Bps of | ||||||||
| Highest % of Total | Time | Return (TSR) (3) | Outperformance | ||||||
| Company | |||||||||
| Owned | Horizon | Over Time Horizon | Over | ||||||
| Time Horizon | |||||||||
| Company | by Trian (1) | (Years) (2) | Stock | S&P 500 (4) | vs. S&P 500 | ||||
| *Wendy’s / Tim Hortons | 20.3 % | 9.4 | 314 | % | 110 | % | 805 | bps | |
| Cadbury / Dr Pepper Snapple | 4.4 % | 8.3 | 261 | % | 78 | % | 944 | ||
| Tiffany & Co. | 8.7 % | 8.2 | 147 | % | 76 | % | 448 | ||
| *Mondelez / Kraft Foods | 3.1 % | 8.0 | 167 | % | 74 | % | 590 | ||
| *H.J. Heinz | 4.3 % | 7.3 | 177 | % | 53 | % | 890 | ||
| *Legg Mason | 11.4 % | 6.2 | 227 | % | 175 | % | 333 | ||
| Family Dollar | 8.5 % | 5.3 | 183 | % | 105 | % | 720 | ||
| Core Trian | Domino’s Pizza | 9.9 % | 4.0 | 518 | % | 72 | % | 4,275 | |
| Investments (5) | State Street | 3.3 % | 4.1 | 90 | % | 77 | % | 201 | |
| *Ingersoll-Rand / Allegion | 7.1 % | 3.2 | 154 | % | 70 | % | 1,575 | ||
| Lazard | 6.0 % | 3.2 | 128 | % | 68 | % | 1,194 | ||
| InterContinental Hotels Group | 4.0 % | 3.1 | 107 | % | 65 | % | 880 | ||
| PepsiCo | 1.3 % | 2.5 | 50 | % | 57 | % | (211 | ) | |
| Danone | 1.0 % | 2.5 | 51 | % | 57 | % | (185 | ) | |
| DuPont | 2.7 % | 2.1 | 54 | % | 42 | % | 485 | ||
| The Bank of New York Mellon | 2.7 % | 1.1 | 33 | % | 17 | % | 1,393 | ||
| Other Trian Investments (at or above 4.2%) (6) | Cracker Barrel Old Country Store | 4.9 % | 9.5 | 410 | % | 112 | % | 1,054 | |
| Cheesecake Factory | 14.0 % | 7.5 | 124 | % | 64 | % | 459 | ||
| Chemtura | 4.3 % | 4.0 | (96 | %) | (7 | %) | (5,320 | ) | |
| Peet’s Coffee & Tea | 4.8 % | 1.8 | 81 | % | 15 | % | 3,008 | ||
| Average Outperformance | 677 | bps | |||||||
| Average Outperformance for Companies on which Nelson Peltz Serves or has Served on the Board | 839 | bps |
Notes
*Denotes a board on which Nelson Peltz serves or has served
(1) Represents the highest percentage of the company’s outstanding shares held across all of Trian’s equity investment vehicles at any point during the life of the investment.
(2) Time horizon is defined as from the date of Trian’s first purchase through the earlier of 4/16/2015 or last day of public trading.
(3) The TSR figures in the column titled “Stock” reflect the change in the stock price of each company referenced plus the effect of dividends received over the relevant time period. The TSR figures in the Stock column should not be construed as an indication of the performance of the funds managed by Trian and it should not be assumed that any or all of these investments were or will be profitable in any of the funds managed by Trian.
(4) We highlight the S&P 500 Index (the “Index”) here only as widely recognized index, however, for various reasons the performance of the Index and that of the individual companies included in this chart may not be comparable. Reference to the S&P 500 used in this chart shall mean the S&P 500 Total Return Index, which includes the price changes of all underlying stocks and all dividends reinvested. S&P data is obtained from Bloomberg using the SPX ticker with the inclusion of dividend re-investment.
(5) This category includes all of the investments made by Trian since Trian’s inception in November 2005 (through March 2015): (i) for which Trian has filed a Schedule 13D or 13G or made a similar non-U.S. filing or other notification with respect to its investment in the company or (ii) that were or are a publicly disclosed activist position in which funds managed by Trian invested at least $700 million of capital (the representative size of Trian’s current activist investments) and where Trian (x) had a designee or nominee on the Board and/or (y) wrote a white paper” and met with management. The companies shown on this page do not represent all of the investments purchased or sold for Trian’s clients.
(6) This category includes all other investments made by Trian since Trian’s inception in November 2005 (through March 2015) in which funds managed by Trian held 4.2% or more of the company’s outstanding shares, the percentage that Trian held in chemical company Chemtura.
Field: Page; Sequence: 8
Field: /Page
APPENDIX C: Third Party Statements
And yet, unlike many other successful businessmen, he remembers what life is like for people such as our members who work on the frontlines. He knows it’s people on the front lines that are the keys to success for any business…
… Wherever we see Nelson Peltz, we see businesses that are adding jobs here in the United States… There is no better example than what happened this year at the Mott’s Apple Sauce Company… After some bad management decisions put hundreds of our members on the streets, we asked Nelson Peltz to intervene. In all my years of dealing with various business leaders – big, medium and small – I can tell you it is rare to see someone step up the way Nelson Peltz did.
As a result, we were able to save family-supporting jobs for hundreds of families in one of the most distressed areas of upstate New York.”
— Stuart Appelbaum, President, RWDSU
— Dennis R. Beresford, Executive in Residence at the Terry College of Business, University of Georgia, Board member of the National Association of Corporate Directors (NACD), and former Director of several public companies, including Legg Mason, Inc.
— Emil J. Brolick, President and CEO, The Wendy’s Company
— Charles E. Bunch, Chairman and CEO, PPG Industries, Inc., and former Director of H.J. Heinz Company
Field: Page; Sequence: 1
Field: /Page
— John T. Cahill, Chairman and CEO, Kraft Foods Group, Lead Independent Director of American Airlines Group, Inc., Director of Colgate-Palmolive Company, and former Director of Legg Mason, Inc.
As an activist investor, Mr Peltz has orchestrated change in many companies that he and his team have considered to be underperforming. Whilst the experience is always testing and sometimes irritating, the rationale for the challenge is invariably based on analytical study and the style of engagement relentless, but reasonable.
Whilst the role of the activist may not always be welcome, there is no doubt that the record of Mr Peltz in contributing to the creation of shareholder value over many years is indisputable.”
— Sir Roger Carr, Former Chairman, Cadbury plc
— Leonard Coleman, Former President, National League of Professional Baseball, and former Director of H.J. Heinz Company
Certainly no one can argue with the strong performance of the company, even in very tumultuous times in the broader market. It is our view that this success is due in large part to the ways that all the major stakeholders came together to ensure that long-term investor needs are met. To be sure, if more companies I interact with were able to follow the Heinz model [where Nelson was a director], I believe we would have… fewer wasted resources spent on distracting fights that are not connected to growing our industries.”
— Bill Dempsey, Former Director, UFCW
Field: Page; Sequence: 2
Field: /Page
— Edith Holiday, Former Director, H.J. Heinz Company, and current Director of various public companies
— Jeff Immelt, Chairman and CEO, GE
— William R. Johnson, Former Chairman and CEO, H. J. Heinz Company, current Director of Emerson Electric Co., United Parcel Service, Inc. and PepsiCo, Inc. (effective March 23, 2015), and current Trian Advisory Partner (“The Innovation Playbook” by J.P. Donlon, Chief Executive Magazine, March 2008)
— Candace Kendle, Former Co-Founder and CEO, Kendle International, and former Director of H.J. Heinz Company
— Kenneth Langone, American businessman and investor, and co-founder of The Home Depot
— Rupert Murdoch, Chairman and CEO, 21st Century Fox, and Executive Chairman and former CEO, News Corp.
— John V. Murphy, Former CEO, Oppenheimer Funds Inc., and Lead Independent Director of Legg Mason, Inc.
Field: Page; Sequence: 3
Field: /Page
— Dean R. O’Hare, Former Chairman and CEO, The Chubb Corporation, Director of AGL Resources and Fluor Corporation, and Former Director of H.J. Heinz Company and DFA Capital Management Inc.
— David Petratis, Chairman, President and CEO, Allegion, plc
— Irene Rosenfeld, Chairman and CEO, Mondelēz International, Inc.
— Todd Stitzer, Chairman, Signet Jewelers, and former CEO, Cadbury plc
— Joseph A. Sullivan, Chairman and CEO, Legg Mason, Inc.
— Richard Swift, Lead Director, Ingersoll-Rand plc
Field: Page; Sequence: 4
Field: /Page
— Thomas J. Usher, Former Chairman and CEO, United States Steel Corporation, non-executive Chairman of the board of Marathon Petroleum Corporation, Director of The PNC Financial Services Group, Inc. and PPG Industries, Inc., and former Director of H.J. Heinz Company
— Larry D. Young, President and Chief Executive Officer, Dr Pepper Snapple Group, Inc.
Forward-Looking Statements
These materials contain forward-looking statements. All statements contained in these materials that are not clearly historical in nature or that necessarily depend on future events are forward-looking, and the words “anticipate,” “believe,” “expect,” “estimate,” “plan” and similar expressions are generally intended to identify forward-looking statements. The projected results and statements contained in these materials or otherwise provided to you that are not historical facts are based on current expectations, speak only as of the date of these materials and involve risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such projected results and statements. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of Trian. Although Trian believes that the assumptions underlying the projected results or forward-looking statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the projected results or forward-looking statements included in these materials or otherwise provided to you will prove to be accurate. In light of the significant uncertainties inherent in the projected results and forward-looking statements included in these materials or otherwise provided to you, the inclusion of such information should not be regarded as a representation as to future results or that the objectives and plans expressed or implied by such projected results and forward-looking statements will be achieved. Trian will not undertake and specifically declines any obligation to disclose the results of any revisions that may be made to any projected results or forward-looking statements in these materials or otherwise provided to you to reflect events or circumstances after the date of such projected results or statements or to reflect the occurrence of anticipated or unanticipated events.
Additional Information
Trian Fund Management, L.P. (“Trian”) and the investment funds that it manages that hold shares of E.I. du Pont de Nemours and Company (collectively, Trian with such funds, “Trian Partners”) together with other Participants (as defined below), filed a definitive proxy statement and an accompanying proxy card with the Securities and Exchange Commission (the “SEC”) on March 25, 2015 to be used to solicit proxies in connection with the 2015 Annual Meeting of Stockholders of E.I. du Pont de Nemours and Company (the “Company”), including any adjournments or postponements thereof or any special meeting that may be called in lieu thereof (the “2015 Annual Meeting”). Information relating to the participants in such proxy solicitation (the “Participants”) has been included in that definitive proxy statement and in any other amendments to that definitive proxy statement. Stockholders are advised to read the definitive proxy statement and any other documents related to the solicitation of stockholders of the Company in connection with the 2015 Annual Meeting because they contain important information, including additional information relating to the Participants. Trian Partners’ definitive proxy statement and a form of proxy have been mailed to stockholders of the Company. These materials and other materials filed by Trian Partners in connection with the solicitation of proxies are available at no charge at the SEC’s website at www.sec.gov. The definitive proxy statement and other relevant documents filed by Trian Partners with the SEC are also available, without charge, by directing a request to Trian’s proxy solicitor, MacKenzie Partners, Inc. 105 Madison Avenue, New York, New York 10016 (call collect: 212-929-5500; call toll free: 800-322-2885) or email: [email protected]
Field: Page; Sequence: 5
Field: /Page
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.